Mifepristone as Adjunctive Therapy in Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Alzheimer's Disease
Interventions
DRUG

Mifepristone

Trial Locations (21)

10021

Eastside Medical Research, New York

15206

Clinical Trials Research Services, Pittsburgh

23229

International Clinical Research Associates, Richmond

23452

International Clinical Research Associates, Virginia Beach

33154

Baumel-Eisner Neuromed Inst, Miami Beach

33321

Baumel-Eisner Neuromed Inst, Fort Lauderdale

33486

Baumel-Eisner Neuromed Inst, Boca Raton

33613

Stedman Clinical Trials, Tampa

33647

Johnnie B. Byrd, Sr. Alzheimer's Center & Research Inst, Tampa

33916

Clinical Physiology Associates, Fort Myers

43623

Neuro Center of Ohio, Toledo

73118

Pahl Pharmaceutical Research, LLC, Oklahoma City

74104

Clinical Pharmaceutical Trials, Inc., Tulsa

76309

Grayline Clinical Drug Trials, Wichita Falls

85210

Pivotal Research Center, Mesa

85381

Pivotal Research Center, Peoria

90505

AVI Clinical Research, Torrance

91403

California Neuroscience Research Medical Group, Inc., Sherman Oaks

92708

ATP Clinical Trials, Fountain Valley

92868

UCI Irvine Medical Center, Orange

07740

Memory Enhancement Center, Long Branch

Sponsors
All Listed Sponsors
collaborator

Institute for the Study of Aging (ISOA)

OTHER

lead

Corcept Therapeutics

INDUSTRY